Advertisement

Molecular Neurobiology

, Volume 53, Issue 10, pp 7028–7036 | Cite as

GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats

  • Wei Wang
  • Mingchang Li
  • Yuefei Wang
  • Qian Li
  • Gang Deng
  • Jieru Wan
  • Qingwu Yang
  • Qianxue Chen
  • Jian Wang
Article

Abstract

Hemorrhagic transformation (HT) is a devastating complication for patients with acute ischemic stroke who are treated with tissue plasminogen activator (tPA). It is associated with high morbidity and mortality, but no effective treatments are currently available to reduce HT risk. Therefore, methods to prevent HT are urgently needed. In this study, we used TWS119, an inhibitor of glycogen synthase kinase 3β (GSK-3β), to evaluate the role of the Wnt/β-catenin signaling pathway in recombinant tPA (rtPA)-induced HT. Sprague–Dawley rats were subjected to a middle cerebral artery occlusion (MCAO) model of ischemic stroke and then were administered rtPA, rtPA combined with TWS119, or vehicle at 4 h. The animals were sacrificed 24 h after infarct induction. Rats treated with rtPA showed evident HT, had more severe neurologic deficit, brain edema, and blood–brain barrier breakdown, and had larger infarction volume than did the vehicle group. Rats treated with TWS119 had significantly improved outcomes compared with those of rats treated with rtPA alone. In addition, Western blot analysis showed that TWS119 increased the protein expression of β-catenin, claudin-3, and ZO-1 while suppressing the expression of GSK-3β. These results suggest that TWS119 reduces rtPA-induced HT and attenuates blood–brain barrier disruption, possibly through activation of the Wnt/β-catenin signaling pathway. This study provides a potential therapeutic strategy to prevent tPA-induced HT after acute ischemic stroke.

Keywords

TWS119 rtPA Hemorrhagic transformation Wnt/β-catenin signaling pathway Ischemic stroke 

Notes

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (81171112, 81371272 to M.C.L., 81372683 to Q.X.C.) and grants from the National Institutes of Health (R01NS078026, R01AT007317 to J. W.). We thank Jiarui Wang and Claire Levine, MS, ELS, for assistance with the manuscript preparation.

Compliance with Ethical Standards

All protocols used in this study were approved by the Institutional Animal Care and Use Committee at Wuhan University.

Conflict of Interest

The authors declare that they have no competing interests.

References

  1. 1.
    Beslow LA, Smith SE, Vossough A, Licht DJ, Kasner SE, Favilla CG, Halperin AR, Gordon DM et al (2011) Hemorrhagic transformation of childhood arterial ischemic stroke. Stroke 42(4):941–946. doi: 10.1161/STROKEAHA.110.604199 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    dela Pena IC, Yoo A, Tajiri N, Acosta SA, Ji X, Kaneko Y, Borlongan CV (2015) Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab 35(2):338–346. doi: 10.1038/jcbfm.2014.208 CrossRefPubMedGoogle Scholar
  3. 3.
    Ozkul-Wermester O, Guegan-Massardier E, Triquenot A, Borden A, Perot G, Gerardin E (2014) Increased blood–brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke. Eur Neurol 72(1–2):45–53. doi: 10.1159/000358297 CrossRefPubMedGoogle Scholar
  4. 4.
    Tan Z, Li X, Turner RC, Logsdon AF, Lucke-Wold B, DiPasquale K, Jeong SS, Chen R et al (2014) Combination treatment of r-tPA and an optimized human apyrase reduces mortality rate and hemorrhagic transformation 6h after ischemic stroke in aged female rats. Eur J Pharmacol 738:368–373. doi: 10.1016/j.ejphar.2014.05.052 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A et al (2014) Effects of tissue plasminogen activator timing on blood–brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. J Neurol Sci 347(1–2):148–154. doi: 10.1016/j.jns.2014.09.036 CrossRefPubMedGoogle Scholar
  6. 6.
    Rosell A, Foerch C, Murata Y, Lo EH (2008) Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir Suppl 105:173–178CrossRefPubMedGoogle Scholar
  7. 7.
    Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35(11 Suppl 1):2726–2730. doi: 10.1161/01.STR.0000143219.16695.af CrossRefPubMedGoogle Scholar
  8. 8.
    Wang W, Li M, Chen Q, Wang J (2015) Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers. Mol Neurobiol 52(3):1572–1579. doi: 10.1007/s12035-014-8952-x CrossRefPubMedGoogle Scholar
  9. 9.
    Liu L, Wan W, Xia S, Kalionis B, Li Y (2014) Dysfunctional Wnt/β-catenin signaling contributes to blood–brain barrier breakdown in Alzheimer’s disease. Neurochem Int 75:19–25. doi: 10.1016/j.neuint.2014.05.004 CrossRefPubMedGoogle Scholar
  10. 10.
    Polakis P (2008) Formation of the blood–brain barrier: Wnt signaling seals the deal. J Cell Biol 183(3):371–373. doi: 10.1083/jcb.200810040 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Zhou Y, Nathans J (2014) Gpr124 controls CNS angiogenesis and blood–brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev Cell 31(2):248–256. doi: 10.1016/j.devcel.2014.08.018 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Caspi M, Perry G, Skalka N, Meisel S, Firsow A, Amit M, Rosin-Arbesfeld R (2014) Aldolase positively regulates of the canonical Wnt signaling pathway. Mol Cancer 13:164. doi: 10.1186/1476-4598-13-164 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kikuchi A (2013) Canonical Wnt signaling pathway and cellular responses. Clin Calcium 23(6):799–807, doi: CliCa1306799807 PubMedGoogle Scholar
  14. 14.
    Han P, Ivanovski S, Crawford R, Xiao Y (2015) Activation of the canonical Wnt signaling pathway induces cementum regeneration. J Bone Miner Res 30(7):1160–1174. doi: 10.1002/jbmr.2445 CrossRefPubMedGoogle Scholar
  15. 15.
    Wang J, Yu L, Jiang C, Chen M, Ou C, Wang J (2013) Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis. Brain Behav Immun 34:56–66. doi: 10.1016/j.bbi.2013.07.010 CrossRefPubMedGoogle Scholar
  16. 16.
    Ding S, Schultz PG (2004) A role for chemistry in stem cell biology. Nat Biotechnol 22(7):833–840. doi: 10.1038/nbt987 CrossRefPubMedGoogle Scholar
  17. 17.
    Grassilli E, Ianzano L, Bonomo S, Missaglia C, Cerrito MG, Giovannoni R, Masiero L, Lavitrano M (2014) GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis. PLoS One 9(7):e100947. doi: 10.1371/journal.pone.0100947 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Yang T, Sun S, Wang T, Tong X, Bi J, Wang Y, Sun Z (2014) Piperlonguminine is neuroprotective in experimental rat stroke. Int Immunopharmacol 23(2):447–451. doi: 10.1016/j.intimp.2014.09.016 CrossRefPubMedGoogle Scholar
  19. 19.
    Zan L, Wu H, Jiang J, Zhao S, Song Y, Teng G, Li H, Jia Y et al (2011) Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema. Neurochem Int 58(8):872–879. doi: 10.1016/j.neuint.2011.02.014 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Thal SC, Luh C, Schaible EV, Timaru-Kast R, Hedrich J, Luhmann HJ, Engelhard K, Zehendner CM (2012) Volatile anesthetics influence blood–brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury. PLoS One 7(12):e50752. doi: 10.1371/journal.pone.0050752 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Wu H, Wu T, Li M, Wang J (2012) Efficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury. Neurobiol Dis 45(1):388–394. doi: 10.1016/j.nbd.2011.08.028 CrossRefPubMedGoogle Scholar
  22. 22.
    Lu A, Suofu Y, Guan F, Broderick JP, Wagner KR, Clark JF (2013) Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1h of cerebral ischemia and 23h of reperfusion. Neuroscience 253:361–367. doi: 10.1016/j.neuroscience.2013.08.068 CrossRefPubMedGoogle Scholar
  23. 23.
    Clevers H, Loh KM, Nusse R (2014) Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 346(6205):1248012. doi: 10.1126/science.1248012 CrossRefPubMedGoogle Scholar
  24. 24.
    Wang J, Liu X, Lu H, Jiang C, Cui X, Yu L, Fu X, Li Q et al (2015) CXCR4+ CD45− BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice. Brain Behav Immun 45:98–108. doi: 10.1016/j.bbi.2014.12.015 CrossRefPubMedGoogle Scholar
  25. 25.
    Zhang W, Davis CM, Edin ML, Lee CR, Zeldin DC, Alkayed NJ (2013) Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury. PLoS One 8(4):e61244. doi: 10.1371/journal.pone.0061244 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Li M, Zhang Z, Sun W, Koehler RC, Huang J (2011) 17β-estradiol attenuates breakdown of blood–brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia. Neurobiol Dis 44(3):277–283. doi: 10.1016/j.nbd.2011.07.004 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Zhao X, Wu T, Chang CF, Wu H, Han X, Li Q, Gao Y, Li Q et al (2015) Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice. Brain Behav Immun 46:293–310. doi: 10.1016/j.bbi.2015.02.011 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wu H, Wu T, Hua W, Dong X, Gao Y, Zhao X, Chen W, Cao W et al (2015) PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice. Neurobiol Aging 36(3):1439–1450. doi: 10.1016/j.neurobiolaging.2014.12.029 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Tran-Dinh A, Levoye A, Lambert G, Louedec L, Journe C, Meilhac O, Amarenco P (2014) Low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition do not increase the risk of hemorrhagic transformation. Stroke 45(10):3086–3088. doi: 10.1161/STROKEAHA.114.005958 CrossRefPubMedGoogle Scholar
  30. 30.
    Kawamura K, Takahashi T, Kanazawa M, Igarashi H, Nakada T, Nishizawa M, Shimohata T (2014) Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats. PLoS One 9(6):e98639. doi: 10.1371/journal.pone.0098639 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Artus C, Glacial F, Ganeshamoorthy K, Ziegler N, Godet M, Guilbert T, Liebner S, Couraud PO (2014) The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells. J Cereb Blood Flow Metab 34(3):433–440. doi: 10.1038/jcbfm.2013.213 CrossRefPubMedGoogle Scholar
  32. 32.
    Paolinelli R, Corada M, Ferrarini L, Devraj K, Artus C, Czupalla CJ, Rudini N, Maddaluno L et al (2013) Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 8(8):e70233. doi: 10.1371/journal.pone.0070233 CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Siegler JE, Alvi M, Boehme AK, Lyerly MJ, Albright KC, Shahripour RB, Rawal PV, Kapoor N et al (2013) Hemorrhagic transformation (HT) and symptomatic intracerebral hemorrhage (sICH) risk prediction models for postthrombolytic hemorrhage in the stroke belt. ISRN Stroke 2013:681673. doi: 10.1155/2013/681673 CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Jin X, Liu J, Liu W (2014) Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis? Curr Neurovasc Res 11(3):254–262CrossRefPubMedGoogle Scholar
  35. 35.
    Song M, Lim J, Yu HY, Park J, Chun JY, Jeong J, Heo J, Kang H et al (2015) Mesenchymal stem cell therapy alleviates interstitial cystitis by activating Wnt signaling pathway. Stem Cells Dev 24(14):1648–1657. doi: 10.1089/scd.2014.0459 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Reis M, Liebner S (2013) Wnt signaling in the vasculature. Exp Cell Res 319(9):1317–1323. doi: 10.1016/j.yexcr.2012.12.023 CrossRefPubMedGoogle Scholar
  37. 37.
    Zhou J, Chen Y, Cao C, Chen X, Gao W, Zhang L (2015) Inactivation of glycogen synthase kinase-3β up-regulates β-catenin and promotes chondrogenesis. Cell Tissue Bank 16(1):135–142. doi: 10.1007/s10561-014-9449-6 CrossRefPubMedGoogle Scholar
  38. 38.
    Ji XK, Xie YK, Zhong JQ, Xu QG, Zeng QQ, Wang Y, Zhang QY, Shan YF (2015) GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway. Acta Pharmacol Sin 36(3):334–342. doi: 10.1038/aps.2014.150 CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Milatz S, Krug SM, Rosenthal R, Gunzel D, Muller D, Schulzke JD, Amasheh S, Fromm M (2010) Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta 1798(11):2048–2057. doi: 10.1016/j.bbamem.2010.07.014 CrossRefPubMedGoogle Scholar
  40. 40.
    Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Adal A, Qi M, Toh J et al (2008) Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res 1203:133–148. doi: 10.1016/j.brainres.2008.01.093 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Kazmierski R, Michalak S, Wencel-Warot A, Nowinski WL (2012) Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology 79(16):1677–1685. doi: 10.1212/WNL.0b013e31826e9a83 CrossRefPubMedGoogle Scholar
  42. 42.
    Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE (2014) Transmembrane proteins of the tight junctions at the blood–brain barrier: structural and functional aspects. Semin Cell Dev Biol 38:16–25. doi: 10.1016/j.semcdb.2014.11.004 CrossRefPubMedGoogle Scholar
  43. 43.
    Zan L, Zhang X, Xi Y, Wu H, Song Y, Teng G, Li H, Qi J et al (2014) Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion. Neuroscience 262:118–128. doi: 10.1016/j.neuroscience.2013.12.060 CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Tornavaca O, Chia M, Dufton N, Almagro LO, Conway DE, Randi AM, Schwartz MA, Matter K et al (2015) ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208(6):821–838. doi: 10.1083/jcb.201404140 CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Neuhaus W, Wirth M, Plattner VE, Germann B, Gabor F, Noe CR (2008) Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood–brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett 446(2–3):59–64. doi: 10.1016/j.neulet.2008.09.025 CrossRefPubMedGoogle Scholar
  46. 46.
    Won S, Lee JH, Wali B, Stein DG, Sayeed I (2014) Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab 34(1):72–80. doi: 10.1038/jcbfm.2013.163 CrossRefPubMedGoogle Scholar
  47. 47.
    Qu B, Liu BR, Du YJ, Chen J, Cheng YQ, Xu W, Wang XH (2014) Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett 7(4):1175–1178. doi: 10.3892/ol.2014.1828 PubMedPubMedCentralGoogle Scholar
  48. 48.
    Ajmone-Cat MA, D’Urso MC, di Blasio G, Brignone MS, De Simone R, Minghetti L (2015) Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells. Brain Behav Immun. doi:10.1016/j.bbi.2015.11.012Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Wei Wang
    • 1
  • Mingchang Li
    • 1
  • Yuefei Wang
    • 1
  • Qian Li
    • 2
  • Gang Deng
    • 1
  • Jieru Wan
    • 2
  • Qingwu Yang
    • 3
  • Qianxue Chen
    • 1
  • Jian Wang
    • 2
  1. 1.Department of NeurosurgeryRenmin Hospital of Wuhan UniversityWuhanChina
  2. 2.Department of Anesthesiology and Critical Care MedicineThe Johns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of NeurologyXinqiao Hospital, Third Military Medical UniversityChongqingChina

Personalised recommendations